Cargando…

Giving a Hand: Synthetic Peptides Boost the Antifungal Activity of Itraconazole against Cryptococcus neoformans

Cryptococcus neoformans is a multidrug-resistant pathogen responsible for infections in immunocompromised patients. Here, itraconazole (ITR), a commercial antifungal drug with low effectiveness against C. neoformans, was combined with different synthetic antimicrobial peptides (SAMPs), Mo-CBP3-PepII...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguiar, Tawanny K. B., Feitosa, Ricardo M., Neto, Nilton A. S., Malveira, Ellen A., Gomes, Francisco I. R., Costa, Ana C. M., Freitas, Cleverson D. T., Mesquita, Felipe P., Souza, Pedro F. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952215/ https://www.ncbi.nlm.nih.gov/pubmed/36830167 http://dx.doi.org/10.3390/antibiotics12020256

Ejemplares similares

Antifungal Potential of Synthetic Peptides against Cryptococcus neoformans: Mechanism of Action Studies Reveal Synthetic Peptides Induce Membrane–Pore Formation, DNA Degradation, and Apoptosis
por: Aguiar, Tawanny K. B., et al.
Publicado: (2022)

No Chance to Survive: Mo-CBP(3)-PepII Synthetic Peptide Acts on Cryptococcus neoformans by Multiple Mechanisms of Action
por: Aguiar, Tawanny K. B., et al.
Publicado: (2023)

Antifungal Susceptibilities of Cryptococcus neoformans
por: Archibald, Lennox K., et al.
Publicado: (2004)

Synergistic Antibiofilm Activity between Synthetic Peptides and Ciprofloxacin against Staphylococcus aureus
por: Neto, Nilton A. S., et al.
Publicado: (2022)

Antifungal potential of punicalagin against Cryptococcus neoformans species complex
por: Silva, Thaísa Cristina, et al.
Publicado: (2018)

Interactions between antifungals and everolimus against Cryptococcus neoformans
por: Liang, Pin, et al.
Publicado: (2023)

Novel Antifungal Activity for the Lectin Scytovirin: Inhibition of Cryptococcus neoformans and Cryptococcus gattii
por: Jones, Tyler H., et al.
Publicado: (2017)

Behind the Curtain: In Silico and In Vitro Experiments Brought to Light New Insights into the Anticryptococcal Action of Synthetic Peptides
por: Aguiar, Tawanny K. B., et al.
Publicado: (2023)

Antifungal activity of liriodenine on clinical strains of Cryptococcus neoformans and Cryptococcus gattii species complexes
por: Levorato-Vinche, Adriele Dandara, et al.
Publicado: (2022)

Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents
por: Pereira de Sa, Nivea, et al.
Publicado: (2021)

The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of Cryptococcus neoformans
por: Momin, Mahek, et al.
Publicado: (2021)

Synthetic Derivatives of Ciclopirox are Effective Inhibitors of Cryptococcus neoformans
por: Lin, Jeffrey, et al.
Publicado: (2021)

Cryptococcus neoformans Database in Synthetic Biology Open Language
por: Garcia de Resende, Sophia, et al.
Publicado: (2022)

Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects
por: Almeida, Fausto, et al.
Publicado: (2017)

New Insights into the Mechanism of Antibacterial Action of Synthetic Peptide Mo-CBP(3)-PepI against Klebsiella pneumoniae
por: Branco, Levi A. C., et al.
Publicado: (2022)

Investigation of Antifungal Mechanisms of Thymol in the Human Fungal Pathogen, Cryptococcus neoformans
por: Jung, Kwang-Woo, et al.
Publicado: (2021)

Antifungal activity of dendritic cell lysosomal proteins against Cryptococcus neoformans
por: Nelson, Benjamin N., et al.
Publicado: (2021)

Antifungal and Anti-Biofilm Activity of Essential Oil Active Components against Cryptococcus neoformans and Cryptococcus laurentii
por: Kumari, Poonam, et al.
Publicado: (2017)

Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms
por: Bezerra, Leandro P., et al.
Publicado: (2022)

Primary Cutaneous Cryptococcosis due to Cryptococcus neoformans in an Immunocompetent Host Treated with Itraconazole and Drainage: Case Report and Review of the Literature
por: Gaviria Morales, Elizabeth, et al.
Publicado: (2021)

etymologia: Cryptococcus neoformans
Publicado: (2008)

The capsule of Cryptococcus neoformans
por: Casadevall, Arturo, et al.
Publicado: (2018)

Essential Gene Discovery in the Basidiomycete Cryptococcus neoformans for Antifungal Drug Target Prioritization
por: Ianiri, Giuseppe, et al.
Publicado: (2015)

851. Metabolic Changes Contributing to Age-Associated Antifungal Tolerance in Cryptococcus neoformans
por: Yoo, Kyungyoon, et al.
Publicado: (2023)

Essential Oil from Croton blanchetianus Leaves: Anticandidal Potential and Mechanisms of Action
por: Malveira, Ellen A., et al.
Publicado: (2022)

In vitro Antifungal Susceptibility Profiles of Cryptococcus neoformans var. grubii and Cryptococcus gattii Clinical Isolates in Guangxi, Southern China
por: Al-Odaini, Najwa, et al.
Publicado: (2021)

The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans
por: Joffe, Luna S., et al.
Publicado: (2017)

First Isolation, Antifungal Susceptibility, and Molecular Characterization of Cryptococcus neoformans from the Environment in Croatia
por: Pllana-Hajdari, Donjeta, et al.
Publicado: (2019)

Cell Wall Integrity Pathway Involved in Morphogenesis, Virulence and Antifungal Susceptibility in Cryptococcus neoformans
por: de Oliveira, Haroldo Cesar, et al.
Publicado: (2021)

Allicin shows antifungal efficacy against Cryptococcus neoformans by blocking the fungal cell membrane
por: Li, Zhun, et al.
Publicado: (2022)

Methods for Antifungal Susceptibility Testing of the Cryptococcus neoformans/C. gattii Complex: Strengths and Limitations
por: Espinel-Ingroff, Ana, et al.
Publicado: (2023)

Synergistic antifungal interaction of N-(butylcarbamothioyl) benzamide and amphotericin B against Cryptococcus neoformans
por: Andriani, Gabriella Maria, et al.
Publicado: (2023)

Environmental Status of Cryptococcus neoformans and Cryptococcus gattii in Colombia
por: Serna-Espinosa, Briggith-Nathalia, et al.
Publicado: (2021)

Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India
por: Gutch, Ruchi Sethi, et al.
Publicado: (2015)

Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?
por: Cano, Edison J, et al.
Publicado: (2020)

Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal
por: Rhome, Ryan, et al.
Publicado: (2011)

Screening and Antifungal Activity of a β-Carboline Derivative against Cryptococcus neoformans and C. gattii
por: Cruz, Kátia Santana, et al.
Publicado: (2019)

Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility
por: Krysan, Damian J., et al.
Publicado: (2019)

Antifungal activity of eugenol on Cryptococcus neoformans biological activity and Cxt1p gene expression
por: Hassanpour, Parviz, et al.
Publicado: (2020)

Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising Candida albicans and/or Cryptococcus neoformans
por: Qian, Weidong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b0bqq7slk30l8bshmb1rg8df1n